Abstract
NERVE growth factor (NGF)1is a member of an expanding family of neurotrophic factors (including brain-derived neurotrophic factor2 and the neurotrophins3,4) that control the development and survival of certain neuronal populations both in the peripheral and in the central nervous systems5. Its biological effects are mediated by a high-affinity ligand–receptor interaction and a tyrosine kinase signalling pathway6,7. A potential use for NGF and its relatives in the treatment of neurological disorders such as Alzheimer's disease8 and Parkinson's disease9 requires an understanding of the structure–function relationships of NGF. NGF is a dimeric molecule, with 118 amino acids per protomer. We report the crystal structure of the murine NGF dimer at 2.3-Å resolution, which reveals a novel protomer structure consisting of three antiparallel pairs of β strands, together forming a flat surface. Two subunits associate through this surface, thus burying a total of 2,332 Å2. Four loop regions, which contain many of the variable residues observed between different NGF-related molecules, may determine the different receptor specificities. A clustering of positively charged side chains may provide a complementary interaction with the acidic low-affinity NGF receptor. The structure provides a model for rational design of analogues of NGF and its relatives and for testing the NGF-receptor recognition determinants critical for signal transduction.
Similar content being viewed by others
References
Levi-Montalcini, R. EMBO J. 6, 1145–1154 (1987).
Leibrock, J. et al. Nature 341, 149–152 (1989).
Hohn, A., Leibrock, J., Bailey, K. & Barde, Y. A. Nature 344, 339–341 (1990).
Hallböök, F., Ibáñez, C. F. & Persson, H. Neuron 6, 845–848 (1991).
Barde, Y. A. Neuron 2, 1525–1534 (1989).
Hempstead, B. L., Martin-Zanca, D., Kaplan, D. R., Parada, L. F. & Chao, M. V. Nature 350, 678–683 (1991).
Kaplan, D. R., Martin-Zanca, D. & Parada, L. F. Nature 350, 158–160 (1991).
Yankner, B. A., Caceres, A. & Duffy, L. K. Proc. natn. Acad. Sci. U.S.A. 87, 9020–9023 (1990).
Hyman, C. et al. Nature 350, 230–232 (1991).
Darling, T. L. & Shooter, E. M. In Methods for Serum-Free Culture of Neuronal and Lymphoid Cells Vol. 4 (eds Barnes, D. W., Sinbasku, D. A. & Sato, G. H.) 79–93 (Liss, New York, 1984).
Wlodawer, A., Hodgson, K. O. & Shooter, E. M. Proc. natn. Acad. Sci. U.S.A. 72, 777–779 (1975).
Leslie, A. G. W. Acta crystallogr. 43, 143–146 (1987).
Angeletti, R. M. & Bradshaw, R. A. Proc. natn. Acad. Sci. U.S.A. 68, 2417–2420 (1971).
Brünger, A. T., Karplus, M. & Petsko, G. A. Acta crystallogr. 45, 50–61 (1989).
Server, A. & Shooter, E. M. Adv. Protein Chem. 31, 339–370 (1977).
Campbell, I. D., Cooke, R. M., Baron, M., Harvey, T. S. & Tappin, M. J. In Progress in Growth Factor Research. Vol. 1 (Waterfield, M. D.) (Pergamon, London, 1989).
Williams, R., Gaber, B. & Gunning, J. J. biol. Chem. 257, 13321–13323 (1982).
Low, B. W. et al. Proc. natn. Acad. Sci. U.S.A. 73, 2991–2994 (1976).
Walkenshaw, M. D., Saenger, W. & Maelicke, A. Proc. natn. Acad. Sci. U.S.A. 77, 2400–2404 (1980).
Almassy, R. J., Fontecilla-Camps, J. C., Suddath, F. L. & Bugg, C. E. J. molec. Biol. 170, 497–527 (1983).
Chothia, C. & Janin, J. Nature 256, 705–708 (1975).
Campbell, I. D. & Cooke, R. M. J. Cell Sci. 13 (suppl.) 5–10 (1990).
Chothia, C. et al. Nature 342, 877–883 (1989).
Rodriguez-Tébar, A., Dechant, G. & Barde, Y. A. Neuron 4, 487–492 (1990).
Squinto, S. P. et al. Cell 65, 885–893 (1991).
Soppet, D. et al. Cell 65, 895–903 (1991).
Lamballe, F., Klein, R. & Barbacid, M. Cell 66, 967–979 (1991).
Ibán̄ez, C. F., Ebendal, T. & Persson, H. EMBO J. 10, 2105–2110 (1991).
Ibán̄ez, C. F., Hallböök, F., Ebendal, T. & Persson, H. EMBO J. 9, 1477–1483 (1990).
Longo, F. M., Yu, T. K. H. & Mobley, W. C. Cell Regulation 1, 189–195 (1990).
Frazier, W. A., Hogue-Angeletti, R., Sherman, R. & Bradshaw, R. A. Biochemistry 12, 3281–3293 (1973).
Dunbar, J. C., Tregear, G. W. & Bradshaw, R. A. J. Protein Chem. 3, 349–356 (1984).
Radeke, M. J., Misko, T. P., Hsu, C., Herzenberg, L. A. & Shooter, E. M. Nature 325, 593–597 (1987).
Leslie, A. G. W., Brick, P. & Wonacott, A. T. Daresbury Lab. Inf. Quart. Prot. Crystallogr. 18, 33–39 (1986).
Jones, T. A. J. appl. Crystallogr. 11, 268–272 (1978).
Dreissen, H. et al. J. appl. Crystallogr. 22, 510–516 (1989).
Hubbard, T. & Blundell, T. L. Protein Eng. 1, 159–171 (1987).
Gilson, M., Sharp, K. & Honig, B. J. comp. Chem. 9, 327–35 (1988).
Flower, D. R. J. mol. Graph. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McDonald, N., Lapatto, R., Rust, J. et al. New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor. Nature 354, 411–414 (1991). https://doi.org/10.1038/354411a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/354411a0
- Springer Nature Limited
This article is cited by
-
Challenges and progress of neurodrug: bioactivities, production and delivery strategies of nerve growth factor protein
Journal of Biological Engineering (2023)
-
A reciprocal feedback between colon cancer cells and Schwann cells promotes the proliferation and metastasis of colon cancer
Journal of Experimental & Clinical Cancer Research (2022)
-
NGF (−198C > T, Ala35Val) and p75NTR (Ser205Leu) gene mutations are associated with liver function in different histopathological profiles of the patients with chronic viral hepatitis in the Brazilian Amazon
Molecular Medicine (2020)
-
Synthesis and In Vitro Neuroprotective Activity of Analogs with Various Spacer Lengths of a Dimeric Dipeptide Mimetic (GK-2) of Nerve Growth Factor
Pharmaceutical Chemistry Journal (2019)
-
Structural insights into SorCS2–Nerve Growth Factor complex formation
Nature Communications (2018)